SMTL ID : 6cn6.1

RORC2 LBD complexed with compound 34

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.45 Å

Oligo State

monomer

Ligands

1 x F7J: 3-cyano-N-{3-[1-(cyclopentanecarbonyl)piperidin-4-yl]-1,4-dimethyl-1H-indol-5-yl}benzamide(Non-covalent)

F7J.1: 26 residues within 4Å: Chain A: C.27, Q.28, L.29, L.34, C.62, H.65, L.66, M.107, R.109, A.110, Y.111, V.118, F.119, F.120, F.130, L.133, C.135, L.138, I.139, I.142, F.143, S.146, H.221, R.224, L.225, F.228 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:L.29, A:M.107, A:A.110, A:V.118, A:V.118, A:V.118, A:F.119, A:L.133, A:L.138, A:R.224, A:L.225 Hydrogen bonds: A:L.29, A:R.109, A:F.119 Water bridges: A:Q.28

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schnute, M.E. et al., Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist. J. Med. Chem. (2018)

Release Date

2018-09-05

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Nuclear receptor ROR-gamma